SCHEMBL75967

SCHEMBL75967

c1ccc(N(c2ccc(-c3ccc(N(c4ccccc4)c4c5ccccc5cc5ccccc45)cc3)cc2)c2c3ccccc3cc3ccccc23)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.38
KDM4E B2RXH2 3/20 0.38
CYP1A2 P05177 3/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
CYP2C19 P33261 2/20 0.38
HSD17B10 Q99714 2/20 0.38
HPGD P15428 2/20 0.38
GLA P06280 1/20 0.38
ALOX5 P09917 1/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
MAPT P10636 2/20 0.38
CYP3A4 P08684 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
APAF1 O14727 1/20 0.36
CASP3 P42574 1/20 0.36
CASP6 P55212 1/20 0.36
SENP8 Q96LD8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7065426 1.00 ALDH1A1 (0.38) ALDH1A1KDM4ECYP1A2MEN1KMT2A
SCHEMBL6846246 0.98 ALDH1A1 (0.38) ALDH1A1KDM4ECYP1A2MEN1KMT2A
SCHEMBL22338754 0.96 ALDH1A1 (0.39) ALDH1A1KDM4ECYP1A2MEN1KMT2A
SCHEMBL6123825 0.94 ALDH1A1 (0.42) ALDH1A1KDM4ECYP1A2MEN1KMT2A
SCHEMBL13658685 0.92 ALDH1A1 (0.39) ALDH1A1KDM4ECYP1A2MEN1KMT2A
SCHEMBL13222560 0.92 ALDH1A1 (0.39) ALDH1A1KDM4ECYP1A2MEN1KMT2A
SCHEMBL13720783 0.92 ALDH1A1 (0.45) ALDH1A1KDM4ECYP1A2MEN1KMT2A
SCHEMBL13720439 0.92 ALDH1A1 (0.45) ALDH1A1KDM4ECYP1A2MEN1KMT2A
SCHEMBL6123822 0.92 ALDH1A1 (0.45) ALDH1A1KDM4ECYP1A2MEN1KMT2A
SCHEMBL13721405 0.92 ALDH1A1 (0.45) ALDH1A1KDM4ECYP1A2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 957 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7175922-B2 Aggregate organic light emitting diode devices with improved operational stability EASTMAN KODAK COMPANY (US) 2007-02-13 US claimed
US-20060021647-A1 Molecular photovoltaics, method of manufacture and articles derived therefrom SABIC INNOVATIVE PLASTICS IP B.V. 2006-02-02 US claimed
US-6967062-B2 White light-emitting OLED device having a blue light-emitting layer doped with an electron-transporting or a hole-transporting material or both EASTMAN KODAK COMPANY (US) 2005-11-22 US claimed
US-20050106415-A1 Aggregate organic light emitting diode devices with improved operational stability EASTMAN KODAK COMPANY 2005-05-19 US claimed
EP-0468528-B1 Electroluminescent device with organic electroluminescent medium EASTMAN KODAK CO (US) 1995-06-21 EP claimed
EP-0468528-A1 Electroluminescent device with organic electroluminescent medium EASTMAN KODAK COMPANY (US) 1992-01-29 EP claimed
US-5061569-A SUPERIOR STABILITY EASTMAN KODAK COMPANY (US) 1991-10-29 US claimed
US-6423429-B1 None US disclosed
US-10998527-B2 Organic electroluminescent device ROHM CO., LTD. (JP) 2021-05-04 US disclosed
US-10934262-B2 Heterocyclic bridged biphenyls UDC IRELAND LIMITED (IE) 2021-03-02 US disclosed
EP-3083881-B1 MOLECULAR GLASS MIXTURES FOR ORGANIC ELECTRONICS APPLICATIONS MOLECULAR GLASSES INC (US) 2020-09-09 EP disclosed
US-10593886-B2 OLED devices with improved lifetime using non-crystallizable molecular glass mixture hosts MOLECULAR GLASSES, INC. (US) 2020-03-17 US disclosed
EP-2265094-B1 LIGHT EMITTING ELEMENT AND DISPLAY PANEL PIONEER CORP (JP) 2020-01-22 EP disclosed
EP-0468440-A2 Organic electroluminescent device with stabilized cathode EASTMAN KODAK COMPANY (US) 1992-01-29 EP disclosed
EP-0468438-A2 Organic electroluminescent device with stabilizing fused metal particle cathode EASTMAN KODAK COMPANY (US) 1992-01-29 EP disclosed
EP-0468528-A1 Electroluminescent device with organic electroluminescent medium EASTMAN KODAK COMPANY (US) 1992-01-29 EP disclosed
EP-0468437-A2 Electroluminescent device with improved cathode EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1992-01-29 EP disclosed
US-5073446-A ORGANIC ELECTROLUMINESCENT DEVICE WITH STABILIZING FUSED METAL PARTICLE CATHODE EASTMAN KODAK COMPANY (US) 1991-12-17 US disclosed
US-5059862-A High stability; compressing aluminum and magnesium EASTMAN KODAK COMPANY (US) 1991-10-22 US disclosed
US-5047687-A Organic electroluminescent device with stabilized cathode EASTMAN KODAK COMPANY (US) 1991-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10934262-B2 Heterocyclic bridged biphenyls BMP2, BPTF, BMP4 ALDH1A1 2127/4885KDM4E 1340/4885CYP1A2 2577/4885
US-10998527-B2 Organic electroluminescent device L1CAM, EML4, EPCAM ALDH1A1 455/4885KDM4E 2095/4885CYP1A2 3103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.